IRIS Accounts Production v23.3.0.418 07883688 director 1.1.23 31.12.23 31.12.23 0 0 false true false false true false Ordinary shares 1.00000 Ordinary shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh078836882022-12-31078836882023-12-31078836882023-01-012023-12-31078836882021-12-31078836882022-01-012022-12-31078836882022-12-3107883688ns10:Originalns15:EnglandWales2023-01-012023-12-3107883688ns14:PoundSterlingns10:Original2023-01-012023-12-3107883688ns10:Originalns10:Director12023-01-012023-12-3107883688ns10:Original2023-01-012023-12-3107883688ns10:Original2023-12-3107883688ns10:Originalns10:PrivateLimitedCompanyLtd2023-01-012023-12-3107883688ns10:Originalns10:SmallEntities2023-01-012023-12-3107883688ns10:Originalns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3107883688ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2023-01-012023-12-3107883688ns10:SmallCompaniesRegimeForAccountsns10:Original2023-01-012023-12-3107883688ns10:Originalns10:FullAccounts2023-01-012023-12-3107883688ns10:Original2022-01-012022-12-3107883688ns10:Originalns10:OrdinaryShareClass12023-01-012023-12-3107883688ns10:Originalns10:RegisteredOffice2023-01-012023-12-3107883688ns10:Original2022-12-3107883688ns10:Originalns5:CurrentFinancialInstruments2023-12-3107883688ns10:Originalns5:CurrentFinancialInstruments2022-12-3107883688ns5:ShareCapitalns10:Original2023-12-3107883688ns5:ShareCapitalns10:Original2022-12-3107883688ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-12-3107883688ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-12-3107883688ns10:Originalns5:PlantMachinery2023-01-012023-12-3107883688ns10:Originalns5:ComputerEquipment2022-12-3107883688ns10:Originalns5:ComputerEquipment2023-01-012023-12-3107883688ns10:Originalns5:ComputerEquipment2023-12-3107883688ns10:Originalns5:ComputerEquipment2022-12-3107883688ns10:Originalns10:OrdinaryShareClass12023-12-31
REGISTERED NUMBER: 07883688 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2023

for

PAUL RICHMAN PATHOLOGY LTD

PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

Contents of the Financial Statements
FOR THE YEAR ENDED 31 DECEMBER 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


PAUL RICHMAN PATHOLOGY LTD

Company Information
FOR THE YEAR ENDED 31 DECEMBER 2023







DIRECTOR: P Richman





REGISTERED OFFICE: Ferrari House
258 Field End Road
Eastcote
Middlesex
HA4 9UU





REGISTERED NUMBER: 07883688 (England and Wales)





ACCOUNTANTS: Diverset Limited
Chartered Accountants
Ferrari House
258 Field End Road
Ruislip
Middlesex
HA4 9UU

PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

Balance Sheet
31 DECEMBER 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,750 382

CURRENT ASSETS
Cash at bank 739,039 696,650

CREDITORS
Amounts falling due within one year 5 12,268 10,779
NET CURRENT ASSETS 726,771 685,871
TOTAL ASSETS LESS CURRENT LIABILITIES 729,521 686,253

PROVISIONS FOR LIABILITIES 523 73
NET ASSETS 728,998 686,180

CAPITAL AND RESERVES
Called up share capital 6 1 1
Retained earnings 728,997 686,179
SHAREHOLDERS' FUNDS 728,998 686,180

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

Balance Sheet - continued
31 DECEMBER 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 6 February 2024 and were signed by:





P Richman - Director


PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

Notes to the Financial Statements
FOR THE YEAR ENDED 31 DECEMBER 2023


1. STATUTORY INFORMATION

Paul Richman Pathology Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents amounts receivable for goods and services net of VAT and trade discounts.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2022 - NIL).

PAUL RICHMAN PATHOLOGY LTD (REGISTERED NUMBER: 07883688)

Notes to the Financial Statements - continued
FOR THE YEAR ENDED 31 DECEMBER 2023


4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 January 2023 1,893
Additions 3,055
At 31 December 2023 4,948
DEPRECIATION
At 1 January 2023 1,511
Charge for year 687
At 31 December 2023 2,198
NET BOOK VALUE
At 31 December 2023 2,750
At 31 December 2022 382

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 10,087 8,412
Other creditors 2,181 2,367
12,268 10,779

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
1 Ordinary shares £1 1 1

7. CONTROLLING PARTY

The controlling party is P Richman.